NEWS

Encouraging Early Results for Prostate Cancer Screening

Dosing of First Patients Shows Encouraging Early Results in the Investigational Use of Tc-99m-iPSMA for […]

EVENTS

SIGN UP FOR OUR NEWSLETTER

CONNECT WITH US

Theranostics: A Smart Bomb for Cancer. Very interesting read by @sloan_kettering about what #radiotheranostics are all about and the promising future of combining #imaging techniques & #targetedtherapy for #cancercare.
#theranostics #seeittreatit
https://t.co/jppAnjdHWx
Dosing of first patients within the #NOBLERegistry shows encouraging early results in the investigational use of 99mTc-iPSMA for #prostatecancer screening.
#seeittreatit #SPECT #precisiononcology #nuclearmedicine #cancercare #theranostics #radioisotopes https://t.co/Bh5RuhL8lB

ABOUT US

What we do…

We strive to connect patients, practitioners and experts in the nuclear medicine field by improving access to cancer treatments and clinical trials worldwide. The Oncidium foundation leads the way in this patient-focused science, by providing support to advance the availability of radiotherapeutics technologies and facilitate worldwide access to patients.

More about us >
Download brochure >

OUR SPONSORS AND SUPPORTERS

TELIX
Chrysalium Consulting
IBA
ICPO Foundation
MEDraysintell
sck cen
SNMMI
Global Morpho Pharma